These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1950546)

  • 1. Ototoxicity of an ototopic preparation--experimental results and clinical facts.
    Halama AR; Wright CG; Meyerhoff WL
    Acta Otorhinolaryngol Belg; 1991; 45(3):279-82. PubMed ID: 1950546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ototoxicity of an ototopical preparation in a primate.
    Wright CG; Halama AR; Meyerhoff WL
    Am J Otol; 1987 Jan; 8(1):56-60. PubMed ID: 3031988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ototoxicity of neomycin and polymyxin B following middle ear application in the chinchilla and baboon.
    Wright CG; Meyerhoff WL; Halama AR
    Am J Otol; 1987 Nov; 8(6):495-9. PubMed ID: 2829633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of ototoxicity from drugs applied topically to the middle ear space.
    Brummett RE; Harris RF; Lindgren JA
    Laryngoscope; 1976 Aug; 86(8):1177-87. PubMed ID: 181649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory effects of otic drops on the middle ear.
    Anderson RG; Wright CG; Meyerhoff WL
    Int J Pediatr Otorhinolaryngol; 1984 May; 7(2):91-5. PubMed ID: 6086545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
    Schwartz RH
    Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ototoxicity of otic drops applied to the middle ear in the chinchilla.
    Wright CG; Meyerhoff WL
    Am J Otolaryngol; 1984; 5(3):166-76. PubMed ID: 6331211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ototoxicity of ear drops: a clinical perspective.
    Linder TE; Zwicky S; Brändle P
    Am J Otol; 1995 Sep; 16(5):653-7. PubMed ID: 8588672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of ototoxicity of common otic drops using isolated cochlear outer hair cells.
    Jinn TH; Kim PD; Russell PT; Church CA; John EO; Jung TT
    Laryngoscope; 2001 Dec; 111(12):2105-8. PubMed ID: 11802005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical otic antibiotics: clinical cochlear ototoxicity and cost consideration.
    Berenholz LP; Burkey JM; Farmer TL; Lippy WH
    Otolaryngol Head Neck Surg; 2006 Aug; 135(2):291-4. PubMed ID: 16890085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of common topical otic preparations on the morphology of isolated cochlear outer hair cells.
    Russell PT; Church CA; Jinn TH; Kim DJ; John EO; Jung TT
    Acta Otolaryngol; 2001 Jan; 121(2):135-9. PubMed ID: 11349764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tympanostomy tubes and otic drops.
    Meyerhoff WL; Morizono T; Wright CG; Shaddock LC; Shea DA; Sikora MA
    Laryngoscope; 1983 Aug; 93(8):1022-7. PubMed ID: 6308368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of ototopical antibiotics.
    Welling DB; Forrest LA; Goll F
    Laryngoscope; 1995 May; 105(5 Pt 1):472-4. PubMed ID: 7760659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory effects of topical antibiotic suspensions containing propylene glycol in chinchilla middle ears.
    Vassalli L; Harris DM; Gradini R; Applebaum EL
    Am J Otolaryngol; 1988; 9(1):1-5. PubMed ID: 2833858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ototoxicity of common topical antimycotic preparations.
    Tom LW
    Laryngoscope; 2000 Apr; 110(4):509-16. PubMed ID: 10763995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Round window membrane permeability during experimental purulent otitis media: altered Cortisporin ototoxicity.
    Ikeda K; Morizono T
    Ann Otol Rhinol Laryngol Suppl; 1990 Jun; 148():46-8. PubMed ID: 2161637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated measurements of compound action potential: evaluation of the ototoxicity of otic drops.
    Morizono T; Tono T; Sano N
    Acta Otolaryngol Suppl; 1992; 493():77-80. PubMed ID: 1636427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
    Rahman A; Rizwan S; Waycaster C; Wall GM
    Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro protection of auditory hair cells by salicylate from the gentamicin-induced but not neomycin-induced cell loss.
    Mazurek B; Lou X; Olze H; Haupt H; Szczepek AJ
    Neurosci Lett; 2012 Jan; 506(1):107-10. PubMed ID: 22075224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity of ototopical drugs: animal modeling.
    Morizono T
    Ann Otol Rhinol Laryngol Suppl; 1990 Jun; 148():42-5. PubMed ID: 2112363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.